The new design is a screw-cage hybrid intended to facilitate insertion and osseointegration, according to a Jan. 23 news release. The device is self-drilling, self-tapping and compresses across the sacroiliac joint.
Sacrix added more graft space, while maintaining the product’s biomechanical and pull-out strength. An orthopedic spine surgeon developed the device with input from pain management and interventional physicians.
The company said it has performed more than 20 labs in 2020 and five labs so far in 2021.
Sacrix is a portfolio company of KICVentures Group, which acquired NanoFuse Biologics in December.
More articles on devices:
Spine surgeon, inventor files patent infringement suit against NuVasive
14 key thoughts on bundled payments in spine surgery
Flexibility, patience & financial stability — 5 spine surgeons on lessons learned in 2020
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
